Skip to main content
. 2021 Apr 22;22:301. doi: 10.1186/s13063-021-05206-8

Table 1.

Primary objective and outcome

Primary objective and outcome measure
Objective Outcome measure Time point(s) of evaluation
To compare 30-day all-cause mortality of 5 to 14 days ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to ESBL or AmpC-producing Enterobacterales Difference in proportion of those dead in each group 30 days after randomisation